3 completed. 3 Phase 3, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Completed 3 |
| Phase 2 | 2 | Completed 2 |
Follow Autoimmune Hepatitis: new trials by email Literature Review of Autoimmune Hepatitis trials Research Report on Autoimmune Hepatitis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| ADCC Mediated B-Cell dEpletion and BAFF-R Blockade VAY736, Placebo - Autoimmune Hepatitis | Phase 2 / Phase 3 | Completed | Novartis Pharmaceuticals | 68 | 2018-02-15 | 2026-02-19 |
| Cyclosporine-A Versus Prednisolone for Induction of Remission in Auto-immune Hepatitis Cyclosporine-A - Autoimmune Hepatitis | Phase 3 | Completed | Tehran University of Medical Sciences | 55 | 2005-12-01 | 2019-07-19 |
| Budesonide 3x3mg/d Versus Prednisone in Active Autoimmune Hepatitis budesonide, prednisone - Autoimmune Hepatitis | Phase 2 / Phase 3 | Completed | Dr. Falk Pharma GmbH | 208 | 2001-03-01 | 2019-05-07 |
Autoimmune Diseases (3) · Digestive System Diseases (3) · Hepatitis (3) · Hepatitis, Chronic (3) · Immune System Diseases (3) · Liver Diseases (3)
Budesonide (1) · Cyclosporins (1) · Prednisone (1) · ianalumab (1)
Dr. Falk Pharma GmbH (1) · Novartis Pharmaceuticals (1) · Tehran University of Medical Sciences (1)
Germany (2) · Argentina (1) · Belgium (1) · Canada (1) · Czechia (1) · Iran (1) · Japan (1) · Spain (1) · Switzerland (1) · United Kingdom (1) · United States (1)
Michael M Manns, Professor (1)
PMID 20600032, PMID 23810723, PMID 35179437, PMID 37722131
2023 (1)